Skip to main content
Equibles

TANG CAPITAL MANAGEMENT LLC

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 1232621 SAN DIEGO, CA
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$98,706,662
+$15,324,689 QoQ
Shares Held
1,568,266
+31.9% QoQ
Ownership
3.57%
of shares outstanding
% of Portfolio
4.51%
of 13F equity value
Holder Rank
#9
of 256 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TANG CAPITAL MANAGEMENT LLC holds $1,792,526,680 across 34 Biotechnology names. TARS ranks #9 (5.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AUPH
Aurinia Pharmaceuticals Inc.
 13,044,106 $221,358,478
2 SYRE
Spyre Therapeutics, Inc.
 1,892,200 $167,989,516
3 MIRM
Mirum Pharmaceuticals, Inc.
 1,236,027 $144,701,680
4 CELC
Celcuity Inc.
 1,314,594 $137,532,824
5 CORT
Corcept Therapeutics Inc
 1,500,000 $130,425,000
6 PTCT
Ptc Therapeutics, Inc.
 1,500,000 $122,355,000
7 LKFT
Lakefront Biotherapeutics NV
 3,785,991 $113,504,010
8 CAPR
Capricor Therapeutics, Inc.
 4,099,900 $98,725,592

All Filings in TARS

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $98,706,662 1,568,266
2026-03-31 $83,381,973 1,188,624
2025-12-31 $97,324,533 1,188,624
2025-09-30 $145,888,585 2,454,797
2025-06-30 $99,443,826 2,454,797
2025-03-31 $126,102,921 2,454,797
2024-12-31 $124,848,109 2,254,797
2024-09-30 $74,160,273 2,254,797
2024-06-30 $61,285,382 2,254,797
2024-03-31 $81,961,870 2,254,797
2023-12-31 $44,647,139 2,204,797
2023-09-30 $38,038,213 2,140,586
2023-06-30 $32,149,385 1,779,158
2023-03-31 $25,569,366 2,034,158
2022-12-31 $29,343,236 2,001,585
2022-09-30 $35,778,334 2,089,856
2022-06-30 $30,431,802 2,084,370
2022-03-31 $5,046,000 300,000